Impact of China’s National Centralized Drug Procurement Policy on pharmaceutical enterprises’ financial performance: a quasi-natural experimental study

INTRODUCTION: In China, the interest relationship between pharmaceutical enterprises and medical institutions has harmed the healthy development of pharmaceutical enterprises. In November 2018, the National Centralized Drug Procurement (NCDP) policy was published. The NCDP policy severs the interest...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zhixuan, Na, Xin, Chu, Shuzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654749/
https://www.ncbi.nlm.nih.gov/pubmed/38026347
http://dx.doi.org/10.3389/fpubh.2023.1227102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654749/
https://www.ncbi.nlm.nih.gov/pubmed/38026347
http://dx.doi.org/10.3389/fpubh.2023.1227102

Ejemplares similares